Article
Genetic and Epigenetic Markers of Lithium Response
29 Jan 2022
Abstract excerpt
The mood stabilizer lithium represents a cornerstone in the long term treatment of bipolar disorder (BD), although with substantial interindividual variability in clinical response. This variability appears to be modulated by genetics, which has been significantly investigated in the last two decades with some promising findings. In addition, recently, the interest in the role of epigenetics has grown...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
